Objective The aim of this study was to determine whether elevated depressive symptoms are associated with metabolic syndrome and its components in the Japanese population. Methods Out of 1,386 male workers who underwent measurements of variables of metabolic syndrome components in their health checkup, 1,186 subjects (44.5 ± 9.6 years) completed the Zung self-rating depression scale (ZSDS) (response rate 85.6%). In this study, metabolic syndrome was defined according to the joint scientific statement proposed by 6 major organizations, including the International Diabetes Federation. Results The overall frequency of elevated depressive symptoms (ZSDS scores !40) was 42.1% (n=499). The incidence of metabolic syndrome was significantly higher in subjects with elevated depressive symptoms than in those without (13.2% vs. 8.9%, p<0.05). Of all the metabolic syndrome components, mean triglyceride levels were significantly higher in subjects with elevated depressive symptoms than in those without [124.7 (95% confidence interval (CI): 117.8-131.7) mg/dL vs. 111.5 (95% CI: 107.2-115.9) mg/dL, p<0.05]. Consequently, hypertriglyceridemia (28.9% vs. 21.0%, p<0.01) was the main component correlated with the between-group difference of metabolic syndrome incidence. In the logistic regression analysis after adjustment for potential confounders, the odds ratio of the total ZSDS scores for the diagnosis of hypertriglyceridemia was 1.52 (95% CI: 1.13-2.04; p<0.01), and the major depressive symptom was psychomotor agitation (odds ratio: 1.47; 95% CI: 1.10-1.94; p<0.01). Conclusion This study showed that elevated depressive symptoms were associated with hypertriglyceridemia in Japanese male workers, which affected the clinical diagnosis of metabolic syndrome.
Introduction
Depression is a common psychiatric disease in the general population and is an independent risk factor for the development of cardiovascular disease (1) . Many clinical studies have shown that depression is a major predictor of cardiovascular outcomes (2, 3) . Research suggests that one plausible potential mechanism is derived from metabolic syndrome (4) . This syndrome is noted worldwide as a possible cause of atherosclerotic cardiovascular disease, and consists of atherogenic dyslipidemia, elevated blood pressure, increased glucose concentration, as well as prothrombotic and proinflammatory states (5, 6) . Recent evidence has shown that not only depression itself but elevated depressive symptoms are associated with metabolic syndrome. A large prospective study has demonstrated that elevated depressive symptoms and the severity of stressful life events were associated with the cumulative prevalence of metabolic syndrome (7) . However, whether elevated depressive symptoms are related to metabolic syndrome and its components remains unclear in the Japanese population. Therefore, to ex-amine the relationship between them, we assessed depressive symptoms by the Zung self-rating depression scale (ZSDS) (8, 9) and measured variables of metabolic syndrome components in Japanese workers. In this study, we chose the ZSDS to evaluate depressive symptoms because it is one of the most well-known instruments used as a screening test in Japanese clinical practice.
Materials and Methods

Study subjects
Out of 1,386 male workers who underwent measurements of variables of metabolic syndrome components, 1,186 subjects aged 19-68 years (44.5 ± 9.6 years) completed the ZSDS in their health checkup (response rate 85.6%). Demographic data and health information were collected by selfadministered questionnaires. Smoking habit and alcohol intake were classified as either current or not. In addition, subjects were asked to estimate their alcohol intake based on "gou", a traditional Japanese drinking unit corresponding to 23 g ethanol. All participants were subjected to a physical examination assessing height, weight, waist circumference, and blood pressure. Waist circumference was taken at the umbilicus and resting blood pressure was measured in the sitting position by trained technicians using a standard mercury sphygmomanometer. Venous blood samples were collected from each subject after 9 hours or overnight fasting. Using automatic measurement devices, serum levels of triglyceride (enzymatic method) and high-density lipoprotein (HDL) cholesterol (direct method), and plasma levels of glucose (hexokinase method) were measured.
This study was conducted in the Nuclear Science Research Institute, Tokai Research and Development Center, Japan Atomic Energy Agency, according to the principles expressed in the Declaration of Helsinki.
Zung self-rating depression scale
For the self-rating depression scale, we used a Japanese version of the ZSDS, for which the question about decreased libido (item 6) is changed from "I still enjoy sex" to "I'm still interested in the opposite sex". In the ZSDS, the subject is asked to rate 20 items of which 10 are worded symptomatically positive and 10 symptomatically negative. Each item is scored according to its severity level on an ordinal scale (1 to 4), where 1= "a little of the time", 2= "some of the time", 3= "good part of the time" and 4= "most of the time". The result of the ZSDS is a total of all items and ranges from 20 to 80. Its reliability and validity has been found to be adequate in several studies in order to measure depressive symptoms (10, 11) . Previous studies showed that a score of !40 was regarded as having elevated depressive symptoms (12, 13) .
Definition of metabolic syndrome
To examine the relationship between elevated depressive symptoms and each metabolic syndrome component, we used the criteria proposed by 6 major world organizations, including the International Diabetes Federation (14, 15) . Subjects with !3 of the following components are considered to have metabolic syndrome: (i) elevated waist circumference defined as waist circumference !90 cm according to the International Diabetes Federation criteria; (ii) elevated triglyceride defined as triglyceride !150 mg/dL or selfreport of taking lipid-lowering medications; (iii) reduced HDL cholesterol defined as HDL cholesterol <40 mg/dL; (iv) elevated blood pressure defined as blood pressure ! 130/85 mmHg or self-report of taking antihypertensive drugs; (v) elevated glucose defined as fasting glucose !100 mg/dL or self-report of taking antidiabetic drugs.
Statistical analysis
Data were expressed as percentage, mean ± SD, or mean with 95% confidence interval (CI), as appropriate according to data distribution. Comparison of continuous variables was performed by an unpaired t test or the Wilcoxon rank-sum test when appropriate. Comparison of categorical variables was evaluated by the chi-square test. After adjusting for potential confounders such as age, smoking habits, alcohol intake, and lipid-lowering, antihypertensive, and antidiabetic medications, the relationships between the total and subscale ZSDS scores and the metabolic syndrome components were examined by logistic regression analysis. A value of p<0.05 was considered to be significant. Statistical analysis was performed using the JMP Statistical Discovery Software for Windows version 8 (SAS Institute Inc., Cary, NC, USA).
Results
Characteristics of study subjects
Out of the 1,186 subjects, 42.1% (n=499) had elevated depressive symptoms (ZSDS scores !40). The characteristics of the study subjects according to elevated depressive symptoms are shown in Table 1 . Mean ZSDS scores were 45.0 (95% CI: 44.6-45.3) in subjects with elevated depressive symptoms and 33.2 (95% CI: 32.9-33.6) in those without (p<0.0001). Mean age and the proportion of subjects aged !40 years were similar between groups. As Table 1 shows, other clinical and demographic parameters were comparable in the two groups.
The ZSDS scores were comparable in younger subjects (<40 years of age, n=373) and older subjects (aged !40 years, n=813) (mean=38.0, 95% CI: 37.3-38.8 vs. mean= 38.2, 95% CI: 37.7-38.7, p=0.6857). Major ZSDS items (mean score !3) in the subjects with elevated depressive symptoms were the following 5 items: diurnal variation (mean=3.41, 95% CI: 3.35-3.47), hopelessness (mean=3.27, 95% CI: 3.21-3.33), confusion (mean=3.15, 95% CI: 3.09-3.20), personal devaluation (mean=3.11, 95% CI: 3.05-3.16) and dissatisfaction (mean=3.06, 95% CI: 3.01-3.11). 
Incidence of metabolic syndrome and its components
The incidence of metabolic syndrome and its components according to elevated depressive symptoms are listed in Table 2. The incidence of metabolic syndrome was significantly higher in subjects with elevated depressive symptoms than in those without (13.2% vs. 8.9%, p=0.0168). This result was consistent (18.2% vs. 12.8%, p=0.0100) even when using the Japanese criteria proposed by the joint committee of 8 medical societies including the Japanese Society of Internal Medicine (16) . Waist circumference, systolic and diastolic blood pressure, and serum levels of HDL cholesterol and fasting glucose did not differ in the two groups, whereas serum mean levels of triglyceride were significantly higher in subjects with elevated depressive symptoms than in those without [124.7 (95% CI: 117.8-131.7) mg/dL vs. 111.5 (107.2-115.9) mg/dL, p=0.0202]. Consequently, the proportion of an elevated triglyceride (hypertriglyceridemia) was significantly higher in subjects with elevated depressive symptoms than in those without (28.9% vs. 21.0%, p= 0.0017), which was the main component correlated with the between-group difference of metabolic syndrome incidence.
Association between ZSDS scores and hypertriglyceridemia
After adjusting for potential confounders, regression analysis was performed to examine associations between ZSDS scores and hypertriglyceridemia ( Table 3 ). The odds ratio of the total ZSDS scores for hypertriglyceridemia was 1.52 (95% CI: 1.13-2.04; p=0.0052). The ZSDS item for the presence of hypertriglyceridemia was psychomotor agitation, restlessness (item 13) (odds ratio: 1.47; 95% CI: 1.10-1.94; p=0.0077), and on the other hand, that for the absence of hypertriglyceridemia was weight loss (item 7) (odds ratio: 0.55; 95% CI: 0.36-0.80; p=0.0030). Moreover, in a receiver operating characteristic curve, the optimal cutoff score yielding the maximum sensitivity plus specificity for predicting hypertriglyceridemia was 40.0, whose sensitivity and specificity were 50.0% and 60.5%, respectively (Fig. 1) . 
Influence of smoking and alcohol on hypertriglyceridemia induced by elevated depressive symptoms
To examine the possible mechanisms for hypertriglyceridemia induced by elevated depressive symptoms, we further evaluated the influence of common behaviors such as smoking status and alcohol intake. The mean levels of triglyceride were significantly higher in current smokers [n= 282, 128.2 (95% CI: 120.1-136.4) mg/dL] than in nonsmokers [n=904, 113.6 (109.2-118.0) mg/dL) (p<0.0001). The incidence of hypertriglyceridemia was comparable in current smokers with and without elevated depressive symptoms (28.5% vs. 29.0%, p=0.9284), whereas that was significantly higher in nonsmokers with elevated depressive symptoms compared to in those without (29.0% vs. 18.7%, p=0.0004). On the other hand, the mean levels of triglyceride did not differ in current drinkers and not drinkers [n=490, 116.8 (95% CI: 110.5-123.0) mg/dL vs. n=696, 117.3 (112.4-122.3) mg/dL, p=0.4342]. The incidence of hypertriglyceridemia was significantly higher in subjects with elevated depressive symptoms than in those without, regardless of alcohol intake (data not shown).
Discussion
This cross-sectional study suggested that elevated depressive symptoms might be associated with a higher proportion of hypertriglyceridemia, and consequently affected the clinical diagnosis of metabolic syndrome in Japanese male workers. It also showed that depressive symptom such as psychomotor agitation, might be linked to hypertriglyceridemia.
Accumulating evidence has shown that depressive symptoms, as well as depression, are a risk factor for cardiovascular disease and metabolic syndrome. Previous prospective studies demonstrated that depressive symptoms predict the risk of stroke, specifically ischemic stroke (17) , and the risk for developing metabolic syndrome (7, 18) . These findings suggest that metabolic syndrome may have a role in the development of cardiovascular disease in patients with depressive symptoms. Thus, associations between depressive symptoms and metabolic syndrome are one of the intriguing topics in internal medicine, but those are not clear in the Japanese population. In this study, we chose the ZSDS to assess depressive symptoms, because it is one of the most wellknown instruments as a screening test not only by psychiatrists but also by doctors of other field's in Japan. Its reliability and validity has been found to be adequate in some studies to measure depressive symptoms (10, 11) .
There are several important findings in this study. First, elevated depressive symptoms are associated with a higher occurrence of hypertriglyceridemia but not with other components, which affects the clinical diagnosis of metabolic syndrome. This result suggests that elevated depressive symptoms may have an early affect on triglyceride levels out of all the metabolic syndrome components. In this study, hypertriglyceridemia induced by elevated depressive symptoms was not observed in current smokers. This may give us several possible mechanisms of the study results. Current smoking is thought to increase fasting and postprandial triglyceride levels through physiological factors such as autonomic nervous system dysregulation, inflammation, insulin resistance, and decreased omega-3 fatty acid levels (19, 20) . Many studies have demonstrated that depressive symptoms are also related to such factors. Patients with elevated depressive symptoms may have not only unhealthy lifestyles but allostasis including autonomic nervous system dysregulation, which may lead to metabolic abnormalities such as increased visceral adiposity, dyslipidemia, elevated blood pressure, and insulin resistance (4, 21) . A previous study suggested that autonomic nervous system dysregulation was independently associated with the presence of metabolic syndrome, the number of metabolic dysregulation as well as all individual components except for HDL cholesterol (22) . In addition, some studies have demonstrated that low levels of omega-3 unsaturated fatty acids are related to depressive symptoms and may play an adjunctive role in the treatment of depressive symptoms and depression (23, 24) . Thus, these findings indicate that elevated depressive symptoms may have an early affect on fasting and postprandial triglyceride levels, although blood samples were basically collected from each subject after at least 9 hours fasting. However, further studies are needed to clarify the mechanisms of hypertriglyceridemia induced by elevated depressive symptoms. The second is that depressive symptom such as psychomotor agitation, was associated with a higher proportion of hypertriglyceridemia. This result indicates that we should give careful consideration to depressive symptoms in subjects with hypertriglyceridemia. The Kuopio Ischemic Heart Disease study showed that hopelessness is a strong predictor of adverse health outcomes such as myocardial infarction and cancer (25) . The Japan public health center-based study, on the other hand, demonstrated that a lower perceived level of life enjoyment was associated with higher risks of cardiovascular disease related morbidity and mortality among middle-aged men (26) . These findings may indicate how we could treat such subjects. Third, the optimal cutoff ZSDS score yielding the maximum sensitivity plus specificity for predicting hypertriglyceridemia was the same value which we used in this study. This cutoff value has been regarded as a mild depressive disorder (12, 13) . Like this value, even minimal elevations in scores of self-rating depression scales are found to have clinical implications (27) . Finally, there were no differences in the ZSDS scores between young-and middle-aged male workers, although a previous report in a Japanese general population showed that a reverse-J-shaped relationship was found between age groups and mean ZSDS scores and the highest mean score was in the age group of 20 to 39 years (28) . We think that this inconsistency is natural since the ZSDS is highly influenced by various factors and specifically it assesses the presence of depressive symptoms over the previous week.
Some limitations apply to this study. First, we could not investigate differences in diet, physical activities and psychotropic medications of the study subjects. The differences may influence an occurrence of hypertriglyceridemia to some extent. Second, we only investigated Japanese male workers. Results of this study might not be consistent with those of a similar study intended for Japanese female workers because women have been shown to have higher rates of depression and lower rates of hypertriglyceridemia than men. For a better understanding of the study results, these effects should be confirmed in Japanese females. Finally, this study could not determine clinical implications or mechanisms from the study results. We hope to conduct other studies in the near future to understand the results in the clinical arena.
In conclusion, this study showed that elevated depressive symptoms were associated with hypertriglyceridemia in Japanese male workers, which consequently affected the clinical diagnosis of metabolic syndrome.
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